QA: G1 Therapeutics Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001560241_2018_G1_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001560241, G1 Therapeutics Inc

  xvar xval
0 AssetsCurrent 104,661,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 510,000
3 remainder_Assets 0
4 LiabilitiesCurrent 11,704,000
5 LiabilitiesNoncurrent 79,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,087,000
9 ResearchAndDevelopmentExpense 53,881,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 847,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 105,171,000
1 Liabilities 11,783,000
2 Expenses 60,968,000
3 Revenues 0
4 StockholdersEquity 93,388,000
5 NetIncome -60,121,000
6 ComprehensiveNetIncome -60,121,000
7 BaseVar 89,384,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.45
9 EconomicCapitalRatio 3.32

Edgar->Model Mapping

Feature Distribution